Maintenance treatment of opioid dependence and patterns of non-prescribed drug use: Results of a 4-year trial

Letters in Drug Design and Discovery

Volumn 3, Issue 10, 2006, Pages 731-740

  Giacomuzzi, Salvatore M ^a,b   Ertl, Markus ^a   Pavlic, Marion ^b   Libiseller, Kathrin ^b   Riemer, Yvonne ^a   Kemmler, Georg ^a   Rössler, Haimo ^a   Grubwieser, Petra ^b   Rabl, Walter ^b   Hinterhuber, H ^a  

^a Innsbruck Medical ^*  (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Addiction; Drug use; Methadone; Opioid dependence; Sublingual buprenorphine

Indexed keywords

ALCOHOL; AMPHETAMINE; BENZODIAZEPINE; BUPRENORPHINE; COCAINE; DIAMORPHINE; DIHYDROCODEINE; METHADONE; MORPHINE; OPIATE;

ADULT; ARTICLE; AUSTRIA; DRUG DEPENDENCE TREATMENT; DRUG DETOXIFICATION; DRUG USE; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METHADONE TREATMENT; OPIATE ADDICTION; OUTPATIENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; URINALYSIS; URINE LEVEL;

EID: 33846117657     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018006778631910     Document Type: Article

References (85)

1. Klee, H.; Morris, J. Addict. Res., 1994, 1, 377-386.
2. Goldstein A.; Herrera J. Drug Alcohol. Depend., 1995, 40, 139-150.
3. Zanis, D.A.; Woody, G.E. Drug Alcohol. Depend., 1998, 52, 257-260.
4. CIDAD. Group of Experts in Demand Reduction August 8-10, 2001, Jamaica.
5. Cone, E.J.; Preston, K.L. Drug Monit., 2002, 24, 193-198.
6. Dole, V.P.; Nyswander, M.E. J. Am. Med. Assoc., 1965, 193, 80-84.
7. Newman, R.G. N. Engl. J. Med., 1987, 317, 447-450.
8. Caplehorn, J.R.M.; Ross, M.W. Int. J. Addict., 1995, 30, 685-698.
9. Bertschy, G. Eur. Arch. Psychiatry Clin. Neurosci., 1995, 245, 114-124.
10. Zaric, G.S.; Barnett, P.G.; Brandeau, M.L. Am. J. Public Health, 2000, 90, 1100-1111.
11. Kolar, A.F.; Brown, B.S.; Weddington, W.W.; Ball, J.C. J. Subst. Abuse. Treat., 1990, 7, 101-107.
12. Schoenbaum, H.; Selwyn, P.A. Am. J .Public Health, 1995, 85, 83-88.
13. Ball, J.C.; Ross, A. The Effectiveness of Methadone Maintenance Treatment, Springer-Verlag: New York, 1991.
14. Maxwell, S.; Shinderman, M. J. Addict. Dis., 2002, 21, 1-12.
15. Kirn, T.F. J. Am. Med. Assoc., 1988, 260, 2970-2971.
16. Walsh, S.L.; Preston, K.L.; Bigelow, G.E.; Stitzer, M.L. J. Pharmacol. Exp. Ther., 1995, 274, 361-372.
17. Kosten, T.R.; Schottenfeld, R.; Ziedonis, D.; Falcioni, J. J. Nerv. Ment. Dis., 1993, 181, 358-364.
18. Strain, E.C.; Stitzer, M.L.; Liebson, I.A.; Bigelow, G.E. Am. J. Psychiatry, 1994, 151, 1025-1030.
19. Ling,W.; Charuvastra, C.; Collins, J.F.; Batki, S.; Brown, L.S.; Kintaudi, P.; Wesson, D.R.; McNicholas, L.; Tusel, D.J. Addiction, 1998, 93, 475-486.
20. Fischer, G.; Etzersdorfer, P.; Eder, H.; Jagsch, R.; Langer, M.; Weninger, M. Eur. Addict. Res., 1998, 4 (Suppl 1), 32-36.
21. West, S.L.; O'Neal, K.K.; Graham, C.W. J. Subst. Abuse., 2000, 12, 405-414.
22. Barnett, P.G.; Zaric, G.S.; Brandeau, M.L. Addiction, 2001b, 96, 1267-1278.
23. Mattick, R.P.; Ali, R.; White, J.M.; O'Brien, S.; Wolk, S.; Danz, C. Addiction, 2003, 98, 441-452.
24. Gandhi D.H.; Jaffe, J.H.; McNary, S.; Kavanagh, G.J.; Hayes, M.; Currens, M. Addiction, 2003, 98, 453-462.
25. Giacomuzzi, S.M.; Riemer, Y.; Ertl, M.; Kemmler, G.; Rössler, H.; Hinterhuber, H.; Kurz, M. Addiction, 2003, 98, 693-702.
26. Jasinski, D.R.; Pevnick, J.; Griffith, J. Arch. Gen. Psychiatry, 1978, 35, 501-516.
27. Bickel, W.K.; Amass, L. Exp. Clin. Psychopharmacol., 1995, 146, 111-118.
28. Ward, J.; Mattick, R.P.; Hall, W. In Methadone Maintenance Treatment and Other Opioid Replacement Therapies, J. Ward, R.P. Mattick & W. Hall, Eds.; Harwood Academic Publisher: Netherlands, 1998; pp. 239-264.
29. Cone, E.J.; Dickerson, S.L. NIDA Res. Monograph, 1992, 128, 46-58.
30. Leri, F.; Bruneau, J.; Stewart, J. Addiction, 2003, 1, 7-22.
31. Chatham, L.R.; Hiller, M.L.; Rowan-Szal, G.A.; Joe, G.W.; Simpson, D.D. Subst. Use Misuse., 1999, 8, 1137-1165.
32. Craddock, S.G.; Rounds-Bryant, J.L.; Flynn, P.M.; Hubbard, R.L. Am. J. Drug Alcohol. Abuse., 1997, 23, 43-59.
33. Giacomuzzi, S.M.; Ertl, M.; Riemer, Y.; Rössler, H.; Vigl, A.; Hinterhuber, H.; Kurz, M. Wien Klin Wochenschr, 2004, 116, 119-127.
34. ÖBIG Bericht zur Drogensituation 2002. Österreichisches Bundesinstitut für Gesundheitswesen - Bundesministerium für soziale Sicherheit und Generationen. 2002. Wien.
35. EMCDDA European Conference on young people and drugs: conclusions. European Monitoring Centre for Drugs and Drug Addiction, released 3.11.2003. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Portugal, 2003.
36. Fischer, G.; Gombas,W.; Eder, H.; Jagsch, R.; Peternell, A.; Stuhlinger, G.; Pezawas, L.; Aschauer, H.N.; Kasper, S. Addiction, 1999, 94, 1337-47.
37. Eder, H.; Fischer, G.; Gomas, W.; Jagsch, R.; Stühlinger, G.; Kasper, S. Eur. Addict. Res., 1998, 4 (Suppl), 3-7.
38. Schottenfeld, R.S.; Pakes, J.R.; Kosten, T. J. Nerv. Ment. Dis., 1998, 186, 1, 713-720.
39. Fudala, P.J.; Woody, G.W. Curr. Psychiatry Rep., 2004, 6, 339-346.
40. Przewlocki, R. Eur. J. Pharmacol., 2004, 500, 331-349.
41. Pons, D.; Fremaux, D.; Duvauchelle, B.; Loas, G.; Compagnon, M. Presse. Med., 2004, 33, 858-861.
42. Wechsberg, W.M.; Flannery, B.; Kasten, J.J.; Suerken, C.; Dunlap, L.; Roussel, A.E.; Crum, L.; Murdoch, O.; Diesenhaus, H. J. Addict. Dis., 2004, 23, 15-31.
43. Martin, J. J. Psychoactive Drugs, 2004, 2, 129-137.
44. Firoz, S.; Carlson, G. Am. J .Geriatr. Psychiatry, 2004, 12, 539-541.
45. Stock, C.; Shum, J.H. J. Pain Palliat Care Pharmacother., 2004, 18, 35-54.
46. Weizman, T.; Gelkopf, M.; Melamed, Y.; Adelson, M.; Bleich, A. Aust. N. Z. J. Psychiatry, 2003, 37, 458-463.
47. Gerra, G.; Borella, F.; Zaimovic, A.; Moi, G.; Bussandri, M.; Bubici, C.; Bertacca, S. Drug Alcohol Depend, 2004b, 75, 37-45.
48. Belding, M.A.; McLellan, A.T.; Zanis, D.A.; Incmikoski, R. J. Subst. Abuse. Treat., 1998a, 15, 485-492.
49. Belding, M.A.; Iguchi, M.Y.; Morral, A.R.; Husband, S.D. J. Pers. Assess., 1998b, 70, 324-339.
50. Carroll, K.M. Addict. Behav., 1997, 22, 233-245.
51. Cumberbatch, Z.; Copersino, M.; Stitzer, M.; Jones, H. Am. J. Drug Alcohol Abuse., 2004, 30, 237-249.
52. Barnett, P.G.; Rodgers, J.H.; Bloch, D.A. Addiction, 2001a, 95, 683-690.
53. Scholz, H. Facts Figures, 2004, 43, 14-15.
54. Cook, P.A.; McVeigh, J.; Syedm Q.; Mutton, K.; Bellis, M.A. Addiction, 2001, 96, 1787-1797.
55. BMGF - Bundesministerium für Gesundheit und Frauen. Suchtgiftbezogene Todesfälle 2002. Bundesministerium für Gesundheit und Frauen, Vienna Austria, 2003.
56. Haltmayer, H.; Schmid, R.; Strobel, S. Untersuchungen über den i.v. Konsum 'harter' Drogen durch Spritzentests. Abschlussbericht des Projektes Nr. 1572, gefördert vom med.-wiss. Fonds des Bürgermeisters der Stadt Wien, 2000.
57. Brewer, C. Bull N. Y. Acad. Med., 1995, 72, 359-370.
58. Sherman, J.P. Med. J. Aust., 1996, 165, 239.
59. Fischer, G.; Presslich, O.; Diamant, K.; Schneider, C.; Pezawa, L.; Kaspar, S. Alcoholism, 1996, 32, 35-43.
60. Kraigher, D.; Ortner, R.; Eder, H.; Schindler, S.; Fischer, G. Wien Klin Wochenschr, 2002, 114, 904-910.
61. Mitchell, T.B.; White, J.M.; Somogyi, A.A.; Bochner, F. Addiction, 2004, 99, 940-945.
62. Oubeid, M.; Bickel, J.T.; Ingram, E.A.; Scott, G.C. Chest, 1990, 98, 237-239.
63. Rhodes, R.E.; Chiles, C.; Vick, W.W. South Med. J., 1991, 84, 929-930.
64. Schmidt, R.A.; Glenny, R.W.; Godwin, J.D.; Hampson, N. B.; Cantino, M.E.; Reichenbach, D.D. Am. Rev. Respir. Dis., 1991, 143, 649-656.
65. Padley, S. P.; Adler, B. D.; Staples, C. A.; Miller, R. R.; Müller, N. L. Radiology, 1993, 186, 125-127.
66. Jones, B.S.; Brancaccio, F.A.; Rodriguez G.A. BUMC Proceedings, 2002, 15, 430-432.
67. Roberts, W.C. BUMC Proceedings, 2002, 15, 260-261.
68. Ganesan, S.; Felo, J.; Saldana, M.; Kalasinsky, V.F.; Lewin-Smith, M.R.; Tomashefski, J.F. Mod. Pathol., 2003, 16, 286-292.
69. Shaw, M.; Brabbins, C.; Ruben, S. Br Med. J., 1994, 308, 1709.
70. Ashton, C.H. In Drugs and Dependence, C.H. Ashton, Ed.; Harwood Academic Publishers: Routledge, London & New York, 2002; pp. 197-212.
71. Schlatter, J.; Sitbon, N.; Saulnier, J.L. Drug Ther. Bull, 1997, 35, 18-22.
72. van Hulten, R.; Bakker, A.B.; Lodder, A.C.; Teeuw, K.B.; Bakker, A.; Leufkens, H.G. Soc. Sci. Med., 2003, 56, 1345-1354.
73. Gossop, M.; Stewart, D.; Browne, N.; Marsden, J. J. Subst. Abuse. Treat., 2003, 4, 313-321.
74. Aghajanian, G.K.; Alreja, M.; Nestler, E.J.; Kogan, J.H. Clin. Neuropharmacol., 1992, 15 (Suppl 1), 143A-144A.
75. Kreek, M.J. Pharmacol. Biochem. Behav., 1997, 57, 551-569.
76. Downey, K.K.; Helmus, T.C.; Schuster, C.R. Exp. Clin. Psychopharmacol., 2000, 2, 176-184.
77. June, H.L.; Cason, C.R.; Chen, S.H.; Lewis, M.J. Psychopharmacology, 1998, 140, 29-37.
78. Musshoff, F.; Lachenmeier, D.W.; Madea, B. Forensic. Sci. Int., 2003, 133, 118-124.
79. Polettini, A.; Groppi, A.; Montagna, M. J. Anal. Toxicol., 1999, 23, 570-576.
80. Ruttenber, A.J.; Kalter, H.D.; Santinga, P. J. Forensic. Sci., 1990, 35, 891-900.
81. Gerra, G.; Angioni, L.; Zaimovic, A.; Moi, G.; Bussandri, M.; Bertacca, S.; Santoro, G.; Gardini, S.; Caccavari, R.; Nicoli, M.A. Subst. Use Misuse., 2004a, 39, 345-367.
82. Gratzer, D.; Levitan, R.D.; Sheldon, T.; Toneatto, T.; Rector, N.A.; Goering, P. J. Affect. Disord., 2004, 79, 209-215.
83. Johnson, R.E.; Jaffe, J.H.; Fudala, P.J. J. .Am. Med. Assoc., 1992, 267, 2750-2755.
84. Pani, P.P.; Maremmani, I.; Pirastu, R.; Tagliamonte, A.; Gessa, G.L. Drug Alcohol Depend., 2000, 260, 39-50.
85. Petitjean, S.; Stohler, R.; Deglon, J.J.; Livoti, S.; Waldvogel, D.; Uehlinger, C.; Ladewig, D. Drug Alcohol Depend., 2001, 62, 97-104.